IP Library Granted Patent US 10,349,966
Granted Patent B2
US 10,349,966 · App. 15/989,912 · Granted Jul 16, 2019

Method for ablating body tissue

Inventors: Hira V. Thapliyal (Los Altos, CA); David A. Gallup (Alameda, CA); James W. Arenson (Woodside, CA)
Assignee: VytronUS, Inc.
A61B17/320068A61B18/1492A61N7/02A61N7/022A61B17/2202A61B18/24A61B2017/003A61B2017/00106A61B2017/00243A61B2017/22024A61B2018/00029A61N2007/0078
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,349,966
App. No.
15/989,912
Granted
Jul 16, 2019
Kind
B2
Abstract

A cardiac ablation method including the following steps: inserting a treatment catheter into an atrium of a heart, the treatment catheter including an ultrasound emitter; positioning the ultrasound emitter to face heart tissue within the left atrium outside of a pulmonary vein; emitting ultrasound energy from the ultrasound emitter while rotating the ultrasound emitter about a rotation axis; and ablating heart tissue with the ultrasound energy to form a lesion outside of a pulmonary vein.

Claims (25)

1. A method for creating a lesion in cardiac tissue, the method comprising:

positioning within the heart of a patient, an ultrasound transducer coupled to a distal portion of a catheter;

sweeping the ultrasound transducer along an ablation path;

creating a transmural lesion by ablating the cardiac tissue with an ultrasound beam from the ultrasound transducer along the ablation path;

identifying a gap distance between the ultrasound transducer and the cardiac tissue;

indicating the gap distance to a user via a color-coded display;

sensing an angle between the ultrasound beam and the tissue; and

manipulating the angle of the ultrasound beam along the path in response to the sensed angle to create the transmural lesion.

2. The method of claim 1 , wherein the lesion is formed without contact between the ultrasound transducer and the target tissue.

3. The method of claim 1 , wherein the same ultrasound transducer senses the angle and creates the transmural lesion.

4. The method of claim 1 , wherein sweeping the ultrasound transducer comprises one or more of bending or rotating the catheter.

5. The method of claim 1 , wherein sweeping the ultrasound transducer comprises moving the catheter with a console and control system coupled to the catheter.

6. The method of claim 1 , wherein manipulating the angle comprises moving the catheter is with a computer-controlled system.

7. The method of claim 1 , wherein sweeping comprises operating the ultrasound transducer in a diagnostic mode, and wherein creating comprises operating the ultrasound transducer in an ablation mode.

8. The method of claim 7 , further comprising regularly converting, on a time-shared basis, from the ablation mode to the diagnostic mode in order to sense the angle.

9. The method of claim 1 , wherein sweeping comprising adjusting the gap distance to ensure that the ultrasound transducer maintains a gap distance close enough to the surface of the cardiac tissue to generate a transmural lesion regardless of cardiac tissue movement associated with the cardiac cycle.

10. The method of claim 1 , further comprising identifying a thickness of the cardiac tissue.

11. The method of claim 10 , further comprising adjusting a sweep rate of the ultrasound transducer along the ablation path based on the identified cardiac tissue thickness to ensure creation of the transmural lesion.

12. The method of claim 10 , further comprising adjusting a power delivered to the ultrasound transducer based on the identified cardiac tissue thickness to ensure creation of the transmural lesion.

13. The method of claim 1 , wherein manipulating comprises manipulating the angle to ensure that the ultrasound beam is substantially orthogonal to the cardiac tissue.

14. The method of claim 1 , further comprising bending the distal portion of the catheter, wherein the catheter comprises at least one pullwire and wherein actuation of the at least one pullwire bends the distal portion of the catheter.

15. The method of claim 1 , wherein sensing the angle comprises generating sound energy with the ultrasound transducer and sensing at least a portion of the sound energy which is reflected back by the cardiac tissue.

16. The method of claim 15 , wherein sensing the angle comprises sensing one or more amplitudes of the reflected sound energy, wherein the amplitude of the reflected sound energy depends on the type of cardiac tissue which reflects the sound energy.

17. The method of claim 16 , further comprising determining a depth of the lesion or a residual tissue depth that is not yet ablated.

18. The method of claim 1 , wherein the ablation path encircles the pulmonary vein.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2020
From: VYTRONUS, INC.
To: AURIS HEALTH, INC.
Reel/Frame 052879/0057 →
RELEASE OF SECURITY INTEREST Recorded Dec 27, 2019
From: SILICON VALLEY BANK
To: VYTRONUS, INC.
Reel/Frame 051435/0001 →
SECURITY INTEREST Recorded Nov 27, 2019
From: VYTRONUS, INC.
To: SILICON VALLEY BANK
Reel/Frame 051147/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2019
From: THAPLIYAL, HIRA V.; GALLUP, DAVID A.; ARENSON, JAMES W.
To: VYTRONUS, INC.
Reel/Frame 049157/0795 →
Continuity (9)
Continuation 15654779 · Jul 20, 2017
Continuation 14083242 · Nov 18, 2013
Continuation 13630652 · Sep 28, 2012
Continuation 13405712 · Feb 27, 0012
Continuation 13092747 · Apr 22, 2011
Continuation 11747862 · May 11, 2007
Provisional Application 60747137 · May 12, 2006
Provisional Application 60919831 · Mar 23, 2007
Related Publication 20180271554A1 · Sep 27, 2018
Cited By (3)
US 12,193,729 US 12,290,307 US 12,678,146